Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Computational modeling and characterization of peptides derived from nanobody complementary-determining region 2 (CDR2) targeting active-state conformation of the β$_2$-adrenergic receptor (β$_2$AR)
ID
Sencanski, Milan
(
Author
),
ID
Glišić, Sanja
(
Author
),
ID
Kubale, Valentina
(
Author
),
ID
Cotman, Marko
(
Author
),
ID
Mavri, Janez
(
Author
),
ID
Vrecl, Milka
(
Author
)
PDF - Presentation file,
Download
(5,53 MB)
MD5: 27318EC81720E6751E6CFC71D21AAF3E
URL - Source URL, Visit
https://www.mdpi.com/2218-273X/14/4/423
Image galllery
Abstract
This study assessed the suitability of the complementarity-determining region 2 (CDR2) of the nanobody (Nb) as a template for the derivation of nanobody-derived peptides (NDPs) targeting active-state β$_2$-adrenergic receptor (β$_2$AR) conformation. Sequences of conformationally selective Nbs favoring the agonist-occupied β$_2$AR were initially analyzed by the informational spectrum method (ISM). The derived NDPs in complex with β$_2$AR were subjected to protein–peptide docking, molecular dynamics (MD) simulations, and metadynamics-based free-energy binding calculations. Computational analyses identified a 25-amino-acid-long CDR2-NDP of Nb71, designated P4, which exhibited the following binding free-energy for the formation of the β$_2$AR:P4 complex (ΔG = −6.8 ± 0.8 kcal/mol or a Ki = 16.5 μM at 310 K) and mapped the β$_2$AR:P4 amino acid interaction network. In vitro characterization showed that P4 (i) can cross the plasma membrane, (ii) reduces the maximum isoproterenol-induced cAMP level by approximately 40% and the isoproterenol potency by up to 20-fold at micromolar concentration, (iii) has a very low affinity to interact with unstimulated β$_2$AR in the cAMP assay, and (iv) cannot reduce the efficacy and potency of the isoproterenol-mediated β$_2$AR/β-arrestin-2 interaction in the BRET$^2$-based recruitment assay. In summary, the CDR2-NDP, P4, binds preferentially to agonist-activated β$_2$AR and disrupts Gαs-mediated signaling.
Language:
English
Keywords:
bioinformatics
,
nanobody-derived peptides
,
complementary-determining region 2
,
molecular modeling
,
β2-adrenergic receptor
,
cell-based in vitro assays
,
computational biology
,
peptides
,
adrenergic receptors
,
in vitro techniques
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
VF - Veterinary Faculty
Publication status:
Published
Publication version:
Version of Record
Year:
2024
Number of pages:
12 str.
Numbering:
Vol. 14, iss. 4, art. 423
PID:
20.500.12556/RUL-164912
UDC:
577
ISSN on article:
2218-273X
DOI:
10.3390/biom14040423
COBISS.SI-ID:
191281155
Publication date in RUL:
15.11.2024
Views:
46
Downloads:
27
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Biomolecules
Shortened title:
Biomolecules
Publisher:
MDPI
ISSN:
2218-273X
COBISS.SI-ID:
519952921
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
bioinformatika
,
peptidi
,
nanotelesa
,
molekularno modeliranje
,
β2-adrenergični receptor
,
in vitro testi
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
BI-RS/20-21-045
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P4-0053
Name:
Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P1-0012
Name:
Molekulske simulacije, bioinformatika in načrtovanje zdravilnih učinkovin
Funder:
MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:
451-03-66/2024-03/200017
Funder:
MESTD - Ministry of Education, Science and Technological Development of Republic of Serbia
Project number:
451-03-66/2024-03/200042
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back